AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$240M-5.9% YoY

Gross Profit

$91M37.8% margin

Operating Income

-$895,000-0.4% margin

Net Income

$5M1.9% margin

EPS (Diluted)

$0.09

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$4M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$455M

Total Liabilities

$117M

Stockholders' Equity

$337M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$240M	$255M	-5.9%
Gross Profit	$91M	$104M	-12.9%
Operating Income	-$895,000	$16M	-105.7%
Net Income	$5M	$11M	-57.2%

AMPH FY 2017 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena